Literature DB >> 35090999

An analysis of public sunscreen distribution in the United States during the COVID-19 pandemic.

Mindy D Szeto1, Ryan E Kokoska2, Jalal Maghfour3, Chandler W Rundle4, Colby L Presley5, Taylor Harp6, Austin Hamp7, Victoria Wegener8, Jeremy Hugh9, Robert P Dellavalle10.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35090999      PMCID: PMC8788093          DOI: 10.1016/j.jaad.2022.01.020

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   15.487


× No keyword cloud information.
To the Editor: The COVID-19 pandemic might have significantly affected consumer preferences and societal behavior regarding sun protection and skin cancer. We present a pandemic-era follow-up of previous research published in the Journal of the American Academy of Dermatology on public use of sunscreen distributed by IMPACT Melanoma, a prominent nationwide sunscreen distributor and nonprofit organization for skin cancer prevention and education. IMPACT Melanoma’s distribution records from 2020 to 2021 were retrospectively analyzed and compared with those from 2018 to 2019. Health care facilities, public health departments, governmental organizations, parks or recreation centers, educational institutions, nonprofits, and private businesses ordered both sunscreen dispensers and cases of different sunscreen types for public use (Fig 1 ). Every sector showed decreases in the overall orders of sunscreen dispensers (−58%) and cases of sunscreen (−68%). Park or recreation center and nonprofit organization total sunscreen and dispenser orders (the most common in 2018-2019) decreased in 2020 to 2021 by 78% and 42%, respectively. Despite nationwide supply chain disruptions, sunscreens remained available for distribution, with hybrid sunscreens ordered most frequently (no chemical and physical sunscreens were ordered in 2020-2021, perhaps because of their growing unpopularity, as discussed previously by Eason et al). Orders of hybrid sunscreen grew by 41%, driven primarily by hospitals, which also ordered more sunscreen dispensers and likely experienced increased volume at facilities and outreach events (eg, vaccination drives) during the COVID-19 pandemic. In total, Wyoming, Maine, South Dakota, and Massachusetts received the most dispensers and sunscreens by state population from 2020 to 2021 (Fig 2 ).
Fig 1

Comparisons of sunscreen and dispenser distribution records by IMPACT Melanoma between 2018 to 2019 and 2020 to 2021 by purchasing organization type. Color Key: Lowest % change Highest % change in 2020-2021 vs 2018-2019. ∗Physical (mineral) sunscreen: BrightGuard Natural Sunscreen (active ingredients: 6% titanium dioxide and 6% zinc oxide). ∗∗Chemical sunscreen: Coppertone Sport Sunscreen (active ingredients: 3% avobenzone, 8% homosalate, 4.5% octisalate, and 6% octocrylene). ∗∗∗Hybrid sunscreen: Hybrid Sport Sunscreen (active ingredients: 7% octyl methoxycinnamate, 1.25% titanium dioxide, 1.25% zinc oxide, and 1.0% octyl salicylate). ˆCase contains 4 individual 1-L bags of sunscreen. ˆˆThe health care facilities included hospitals, clinics, nursing homes, and cancer centers.

Fig 2

Total sunscreen dispensers and cases of sunscreen distributed by IMPACT Melanoma by state per 1 million individuals from 2020 to 2021. State resident population based on United States Census Bureau 2020 data.

Comparisons of sunscreen and dispenser distribution records by IMPACT Melanoma between 2018 to 2019 and 2020 to 2021 by purchasing organization type. Color Key: Lowest % change Highest % change in 2020-2021 vs 2018-2019. ∗Physical (mineral) sunscreen: BrightGuard Natural Sunscreen (active ingredients: 6% titanium dioxide and 6% zinc oxide). ∗∗Chemical sunscreen: Coppertone Sport Sunscreen (active ingredients: 3% avobenzone, 8% homosalate, 4.5% octisalate, and 6% octocrylene). ∗∗∗Hybrid sunscreen: Hybrid Sport Sunscreen (active ingredients: 7% octyl methoxycinnamate, 1.25% titanium dioxide, 1.25% zinc oxide, and 1.0% octyl salicylate). ˆCase contains 4 individual 1-L bags of sunscreen. ˆˆThe health care facilities included hospitals, clinics, nursing homes, and cancer centers. Total sunscreen dispensers and cases of sunscreen distributed by IMPACT Melanoma by state per 1 million individuals from 2020 to 2021. State resident population based on United States Census Bureau 2020 data. With social distancing, mask mandates, stay-at-home orders, and popularity of outdoor activities in flux, it remains unclear how COVID-19 has affected cumulative UV exposure. However, reduced public access to sunscreen is concerning and corroborates broader pandemic patterns of falling retail consumer sunscreen sales. Furthermore, declining Google search volumes for sunburns and precancerous or cancerous UV exposure-related dermatologic conditions could suggest a waning consumer interest in sun protection and consequent sun damage, as well as a decreased public perception of UV exposure risk. Additionally, required mask-wearing in public settings might contribute to reduced sunscreen use because combining masks with sunscreens can cause skin irritation, pruritus, and occlusion. Additionally, some may equate mask use to sufficient sun protection, although masks confer unknown and variable UV protection. Further research should directly investigate changes in individuals’ sunscreen application behaviors. Although limited by our 2-year periods of organizational distribution analysis, our findings highlight worrisome trends that may be suggestive of increased sun damage risk and warrant additional investigation. Consumer research has suggested that the pandemic has eroded consumer attitudes regarding sun protection, and a large fraction now only uses sunscreen on an as-needed basis (eg, long beach vacations or special occasions). Dermatologists can encourage greater awareness about sun protection for everyday outdoor experiences, for indoors, and during colder months, regardless of COVID-19–induced changes and mask-wearing. IMPACT Melanoma’s touch-free automated sunscreen dispensers and extensive virtual or online outreach programs will be advantageous. However, melanoma rates continue to rise, and the pandemic’s long-term effects are yet to be seen. As sunscreen application and UV exposure data become available in the near future, further examination of UV-associated skin cancer by state or region may be useful in informing outreach efforts and policy.

Conflicts of interest

Dr Dellavalle is a Joint Coordinating Editor for Cochrane Skin, a dermatology section editor for UpToDate, a Social Media Editor for the Journal of the American Academy of Dermatology (JAAD), a Podcast Editor for the Journal of Investigative Dermatology (JID), the Editor-in-Chief of the Journal of Medical Internet Research (JMIR) Dermatology, a coordinating editor representative of the Cochrane Council, and the Co-Chair of the Colorado Skin Cancer Task Force. Dr Dellavalle receives editorial stipends (JAAD and JID), royalties (UpToDate), and expense reimbursement from Cochrane Skin. Dr Hugh participated in fundraising for IMPACT Melanoma. Drs Maghfour, Rundle, and Presley and Authors Szeto, Kokoska, Harp, Hamp, and Wegener have no conflicts of interest to declare.
  4 in total

1.  Occlusion and face masks: Issues with sunscreen use among health care workers during COVID-19.

Authors:  Subuhi Kaul; Deepak Jakhar; Ishmeet Kaur
Journal:  Dermatol Ther       Date:  2020-09-11       Impact factor: 2.851

2.  National trends in free public sunscreen dispensers.

Authors:  Chelsea D Eason; Chandler Rundle; Cory A Dunnick; Jeremy Hugh; Robert P Dellavalle
Journal:  J Am Acad Dermatol       Date:  2020-06-03       Impact factor: 11.527

3.  Changes in Google search for "sunburn" during the COVID-19 pandemic.

Authors:  Wyatt Boothby-Shoemaker; Henry W Lim; Indermeet Kohli; David M Ozog
Journal:  Photodermatol Photoimmunol Photomed       Date:  2021-04-17       Impact factor: 3.254

4.  Analysis of dermatology-related search engine trends during the COVID-19 pandemic: Implications for patient demand for outpatient services and telehealth.

Authors:  Anthony K Guzman; John S Barbieri
Journal:  J Am Acad Dermatol       Date:  2020-06-04       Impact factor: 11.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.